Literature DB >> 3066501

Side-effects of non-steroidal anti-inflammatory drugs.

D A Henry.   

Abstract

Despite a continuing lack of good quality epidemiological studies, our knowledge of the side-effects of NSAIDs has advanced in recent years. The most important reactions are those which are related predictably to the pharmacology of the drugs and these need to be considered whenever a NSAID is prescribed, particularly for patients who can be identified as belonging to high-risk groups. The important reactions are: 1. Gastrointestinal damage, which is now known to extend to some degree from the oesophagus to the rectum, although the acid contact areas of the stomach and duodenum are the most important. Although the studies have produced heterogeneous results, NSAIDs probably double or triple the risk of an individual developing serious gastrointestinal haemorrhage or perforation. The risk increases with age and previous history of ulceration, and, in communities with particularly high use of NSAIDs, the drugs may account for up to 30% of all cases of ulcer complications. 2. Renal syndromes, of which functional renal impairment is the most important. This may precipitate cardiac failure, and hyperkalaemia is an additional hazard. Antagonism of the action of diuretics may contribute to the fluid retention, and antagonism of antihypertensive therapy is probably quite common and may result in additional unnecessary therapy. Patients at risk of functional renal impairment from NSAIDs can be identified readily and in these subjects the drugs have to be used with great care and with appropriate monitoring. 3. Respiratory effects, in particular acute bronchospasm in subjects with a history of aspirin sensitivity. NSAIDs should be used with caution in asthmatics, and patients purchasing NSAIDs without prescriptions need to be warned of these effects. Other uncommon serious reactions include hepatocellular damage, acute interstitial nephritis, agranulocytosis and aplastic anaemia, Stevens-Johnson syndrome and toxic epidermal necrolysis. These are unpredictable reactions which generally need not be considered before prescribing. However, in patients who present with any of these conditions, NSAIDs, because of their wide use, should always be considered as a possible cause.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3066501     DOI: 10.1016/s0950-3579(88)80021-9

Source DB:  PubMed          Journal:  Baillieres Clin Rheumatol        ISSN: 0950-3579


  10 in total

1.  Neuropsychiatric reactions to nonsteroidal anti-inflammatory drugs (NSAIDs). The New Zealand experience.

Authors:  D W Clark; K Ghose
Journal:  Drug Saf       Date:  1992 Nov-Dec       Impact factor: 5.606

Review 2.  Clinical pharmacokinetics and pharmacodynamics of celecoxib: a selective cyclo-oxygenase-2 inhibitor.

Authors:  N M Davies; A J McLachlan; R O Day; K M Williams
Journal:  Clin Pharmacokinet       Date:  2000-03       Impact factor: 6.447

Review 3.  The problems and pitfalls of NSAID therapy in the elderly (Part II).

Authors:  A G Johnson; R O Day
Journal:  Drugs Aging       Date:  1991-05       Impact factor: 3.923

4.  Non-steroidal anti-inflammatory drugs and hypertension in the elderly: a community-based cross-sectional study.

Authors:  A G Johnson; L A Simons; J Simons; Y Friedlander; J McCallum
Journal:  Br J Clin Pharmacol       Date:  1993-05       Impact factor: 4.335

5.  Rebamipide protects small intestinal mucosal injuries caused by indomethacin by modulating intestinal microbiota and the gene expression in intestinal mucosa in a rat model.

Authors:  Satoshi Kurata; Takako Nakashima; Takako Osaki; Naoya Uematsu; Masafumi Shibamori; Kazushi Sakurai; Shigeru Kamiya
Journal:  J Clin Biochem Nutr       Date:  2014-10-04       Impact factor: 3.114

6.  Intra-articular biomaterials-assisted delivery to treat temporomandibular joint disorders.

Authors:  Khandmaa Dashnyam; Jung-Hwan Lee; Nandin Mandakhbayar; Guang-Zhen Jin; Hae-Hyoung Lee; Hae-Won Kim
Journal:  J Tissue Eng       Date:  2018-05-13       Impact factor: 7.813

7.  Biological Activity of fac-[Re(CO)3(phen)(aspirin)], fac-[Re(CO)3(phen)(indomethacin)] and Their Original Counterparts against Ishikawa and HEC-1A Endometrial Cancer Cells.

Authors:  Olga Kuźmycz; Aleksandra Kowalczyk; Paweł Stączek
Journal:  Int J Mol Sci       Date:  2022-09-30       Impact factor: 6.208

8.  Editorial: One Step at a Time: Advances in Osteoarthritis.

Authors:  Ali Mobasheri; Troy N Trumble; Christopher R Byron
Journal:  Front Vet Sci       Date:  2021-07-16

9.  Design, Synthesis, and Biological Evaluation of New 2-Phenyl-4H-chromen-4-one Derivatives as Selective Cyclooxygenase-2 Inhibitors.

Authors:  Afshin Zarghi; Samaneh Kakhki
Journal:  Sci Pharm       Date:  2014-09-15

10.  QSAR Modeling of COX -2 Inhibitory Activity of Some Dihydropyridine and Hydroquinoline Derivatives Using Multiple Linear Regression (MLR) Method.

Authors:  Somaye Akbari; Tannaz Zebardast; Afshin Zarghi; Zahra Hajimahdi
Journal:  Iran J Pharm Res       Date:  2017       Impact factor: 1.696

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.